Focus Partners Wealth Acquires 219,979 Shares of CVS Health Corporation $CVS

Focus Partners Wealth lifted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 73.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 517,967 shares of the pharmacy operator’s stock after acquiring an additional 219,979 shares during the period. Focus Partners Wealth’s holdings in CVS Health were worth $40,943,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in CVS. Caitong International Asset Management Co. Ltd increased its position in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 281 shares in the last quarter. Swiss RE Ltd. bought a new stake in shares of CVS Health during the fourth quarter worth about $26,000. Ares Financial Consulting LLC bought a new stake in shares of CVS Health during the fourth quarter worth about $29,000. Dogwood Wealth Management LLC increased its position in shares of CVS Health by 93.7% during the fourth quarter. Dogwood Wealth Management LLC now owns 370 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 179 shares in the last quarter. Finally, GoalVest Advisory LLC bought a new stake in shares of CVS Health during the fourth quarter worth about $32,000. 80.66% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have issued reports on CVS. Argus upped their price objective on shares of CVS Health from $90.00 to $104.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Wells Fargo & Company upped their price objective on shares of CVS Health from $102.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, May 8th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of CVS Health in a research report on Thursday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of CVS Health in a research report on Friday, May 8th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $113.00 price objective on shares of CVS Health in a research report on Monday, June 1st. Twenty-two equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $100.68.

CVS Health Stock Down 1.2%

CVS Health stock opened at $100.69 on Tuesday. CVS Health Corporation has a twelve month low of $58.50 and a twelve month high of $102.77. The firm has a 50 day moving average price of $87.46 and a 200-day moving average price of $80.96. The company has a market capitalization of $128.47 billion, a P/E ratio of 44.36, a P/E/G ratio of 1.00 and a beta of 0.62. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, beating analysts’ consensus estimates of $2.21 by $0.36. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The firm had revenue of $100.43 billion during the quarter, compared to the consensus estimate of $94.99 billion. During the same period in the prior year, the firm earned $2.25 EPS. The company’s revenue was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. As a group, equities analysts predict that CVS Health Corporation will post 7.44 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend was Thursday, April 23rd. CVS Health’s dividend payout ratio is currently 117.18%.

Insider Buying and Selling

In other news, Director Larry Robbins sold 1,983,538 shares of the stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $94.45, for a total transaction of $187,345,164.10. Following the completion of the transaction, the director directly owned 6,213,261 shares of the company’s stock, valued at $586,842,501.45. This represents a 24.20% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Tilak Mandadi sold 69,551 shares of the stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the transaction, the executive vice president directly owned 10,133 shares of the company’s stock, valued at $907,714.14. This represents a 87.28% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 3,441,551 shares of company stock valued at $323,703,977 over the last three months. Insiders own 0.85% of the company’s stock.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.